Publications by authors named "Gary Archer"

Claim this Profile
I
IL-7-mediated expansion of autologous lymphocytes increases CD8+ VLA-4 expression and accumulation in glioblastoma models.
Kirit Singh, Kelly M Hotchkiss, Sarah L Cook, Pamy Noldner, Ying Zhou, Gary E Archer

J Clin Invest· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-7-mediated expansion of autologous lymphocytes increases CD8 VLA-4 expression and accumulation in glioblastoma models.
Kirit Singh, Kelly M Hotchkiss, Sarah L Cook, Pamy Noldner, Ying Zhou, Gary E Archer

bioRxiv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A conjoined universal helper epitope can unveil antitumor effects of a neoantigen vaccine targeting an MHC class I-restricted neoepitope.
Adam M Swartz, Kendra L Congdon, Smita K Nair, Qi-Jing Li, James E Herndon, Gary E Archer

NPJ Vaccines· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GLP toxicology study of a fully-human T cell redirecting CD3:EGFRvIII binding immunotherapeutic bispecific antibody.
Patrick C Gedeon, Michael A Streicker, Teilo H Schaller, Gary E Archer, Micheal P Jokinen

PLoS One· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic virus-derived type I interferon restricts CAR T cell therapy.
Laura Evgin, Amanda L Huff, Phonphimon Wongthida, Jill Thompson, Tim Kottke, Gary Archer

Nat Commun· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preventing Lck Activation in CAR T Cells Confers Treg Resistance but Requires 4-1BB Signaling for Them to Persist and Treat Solid Tumors in Nonlymphodepleted Hosts.
Carter M Suryadevara, Rupen Desai, S Harrison Farber, Bryan D Choi, Adam M Swartz, Gary E Archer

Clin Cancer Res· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening Clinical Cell Products for Replication Competent Retrovirus: The National Gene Vector Biorepository Experience.
Kenneth Cornetta, Lisa Duffy, Steven A Feldman, Crystal L Mackall, Marco L Davila, Gary Archer

Mol Ther Methods Clin Dev· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma.
Patrick C Gedeon, Teilo H Schaller, Satish K Chitneni, Bryan D Choi, Chien-Tsun Kuan, Gary E Archer

Clin Cancer Res· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temozolomide lymphodepletion enhances CAR abundance and correlates with antitumor efficacy against established glioblastoma.
Carter M Suryadevara, Rupen Desai, Melissa L Abel, Katherine A Riccione, Kristen A Batich, Gary E Archer

Oncoimmunology· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma.
Elizabeth A Reap, Carter M Suryadevara, Kristen A Batich, Luis Sanchez-Perez, Gary E Archer

Cancer Res· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination.
Kristen A Batich, Elizabeth A Reap, Gary E Archer, Luis Sanchez-Perez, Smita K Nair

Clin Cancer Res· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study.
James Schuster, Rose K Lai, Lawrence D Recht, David A Reardon, Nina A Paleologos, Gary E Archer

Neuro Oncol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe adverse immunologic reaction in a patient with glioblastoma receiving autologous dendritic cell vaccines combined with GM-CSF and dose-intensified temozolomide.
Duane A Mitchell, Elias J Sayour, Elizabeth Reap, Robert Schmittling, Gabriel DeLeon, Gary Archer

Cancer Immunol Res· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients.
Duane A Mitchell, Kristen A Batich, Michael D Gunn, Min-Nung Huang, Luis Sanchez-Perez, Gary E Archer

Nature· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EGFRvIII-specific chimeric antigen receptor T cells migrate to and kill tumor deposits infiltrating the brain parenchyma in an invasive xenograft model of glioblastoma.
Hongsheng Miao, Bryan D Choi, Carter M Suryadevara, Luis Sanchez-Perez, Shicheng Yang, Gary E Archer

PLoS One· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recognition and killing of autologous, primary glioblastoma tumor cells by human cytomegalovirus pp65-specific cytotoxic T cells.
Smita K Nair, Gabriel De Leon, David Boczkowski, Robert Schmittling, Weihua Xie, Gary E Archer

Clin Cancer Res· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cytokine cocktail directly modulates the phenotype of DC-enriched anti-tumor T cells to convey potent anti-tumor activities in a murine model.
Shicheng Yang, Gary E Archer, Catherine E Flores, Duane A Mitchell, John H Sampson

Cancer Immunol Immunother· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloablative temozolomide enhances CD8⁺ T-cell responses to vaccine and is required for efficacy against brain tumors in mice.
Luis A Sanchez-Perez, Bryan D Choi, Gary E Archer, Xiuyu Cui, Catherine Flores

PLoS One· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rational design and generation of recombinant control reagents for bispecific antibodies through CDR mutagenesis.
Bryan D Choi, Patrick C Gedeon, Chien-Tsun Kuan, Luis Sanchez-Perez, Gary E Archer

J Immunol Methods· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human regulatory T cells kill tumor cells through granzyme-dependent cytotoxicity upon retargeting with a bispecific antibody.
Bryan D Choi, Patrick C Gedeon, James E Herndon, Gary E Archer, Elizabeth A Reap

Cancer Immunol Res· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melanoma immunotherapy using mature DCs expressing the constitutive proteasome.
Jens Dannull, N Rebecca Haley, Gary Archer, Smita Nair, David Boczkowski

J Clin Invest· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral glioma.
Bryan D Choi, Chien-Tsun Kuan, Mingqing Cai, Gary E Archer, Duane A Mitchell

Proc Natl Acad Sci U S A· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot study of IL-2Rα blockade during lymphopenia depletes regulatory T-cells and correlates with enhanced immunity in patients with glioblastoma.
John H Sampson, Robert J Schmittling, Gary E Archer, Kendra L Congdon, Smita K Nair

PLoS One· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoclonal antibody blockade of IL-2 receptor α during lymphopenia selectively depletes regulatory T cells in mice and humans.
Duane A Mitchell, Xiuyu Cui, Robert J Schmittling, Luis Sanchez-Perez, David J Snyder, Gary E Archer

Blood· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma.
John H Sampson, Kenneth D Aldape, Gary E Archer, April Coan, Annick Desjardins

Neuro Oncol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis